IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML

Clinical trial NCT06418776 · RECRUITING

Trial details

NCT number: NCT06418776
Sponsor: National Research Center for Hematology, Russia
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Acute Myeloid Leukemia Early Relapses of Acute Myeloid Leukemia

Start date: 2024-04-01
Primary completion: 2027-04-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.